Treace Medical Concepts (TMCI) Other Non-Current Liabilities (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Other Non-Current Liabilities came in at $3.0 million in Q1 2026, up 8140.54% YoY from $37000.0 in Q1 2025, and up 2209.85% on a QoQ basis from $132000.0 in Q4 2025.
Treace Medical Concepts (TMCI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Other Non-Current Liabilities data on file, last reported at $3.0 million in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 8140.54% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 8140.54% YoY) and the FY2025 annual result came in at $132000.0, up 256.76% from the prior year.
- Other Non-Current Liabilities improved to $3.0 million in Q1 2026, from $132000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $3.0 million in Q1 2026 to a low of $25000.0 in Q1 2023.
- A 5-year average of $288071.4 and a median of $44000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities slumped 69.88% — and 2026, when it surged 8140.54%.
- Tracing TMCI's Other Non-Current Liabilities over 5 years: stood at $83000.0 in 2022, then slumped by 38.55% to $51000.0 in 2023, then dropped by 27.45% to $37000.0 in 2024, then surged by 256.76% to $132000.0 in 2025, then soared by 2209.85% to $3.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $3.0 million (Q1 2026), $132000.0 (Q4 2025), and $190000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Treace Medical Concepts | 290.12 Mn | 244.50 Mn | 35.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.69 Mn |
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 190,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 37,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Mar 31, 2022 | 83,000.00 |
| Dec 31, 2021 | 173,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 245,000.00 |
| Mar 31, 2021 | 245,000.00 |
| Dec 31, 2020 | 245,000.00 |